Organogenesis Holdings (ORGO) Accumulated Expenses (2015 - 2026)

Organogenesis Holdings' Accumulated Expenses history runs 12 years deep, the most recent figure standing at $37.7 million for Q1 2026.

• In Q1 2026, Accumulated Expenses rose 21.03% year-over-year to $37.7 million; the TTM figure through Mar 2026 stood at $37.7 million (up 21.03% YoY), while the FY2025 annual figure was $49.5 million, up 25.55% from the prior year.
• Accumulated Expenses was $37.7 million for Q1 2026 at Organogenesis Holdings, down from $49.5 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $49.5 million in Q4 2025 to a low of $2.4 million in Q1 2024.
• Historically, Accumulated Expenses has averaged $32.6 million across 5 years, with a median of $34.2 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Accumulated Expenses slumped 91.44% in 2024, then jumped 1171.85% in 2025.
• A 5-year view of Accumulated Expenses shows it stood at $26.4 million in 2022, then increased by 13.71% to $30.1 million in 2023, then soared by 31.19% to $39.5 million in 2024, then increased by 25.55% to $49.5 million in 2025, then declined by 23.92% to $37.7 million in 2026.
• The last three Accumulated Expenses figures came in at $37.7 million (Q1 2026), $49.5 million (Q4 2025), and $40.3 million (Q3 2025), per Business Quant data.